Optimal haemoglobin during treatment with recombinant human erythropoietin

被引:30
作者
Ritz, E [1 ]
Amann, K [1 ]
机构
[1] Heidelberg Univ, Dept Internal Med, D-69115 Heidelberg, Germany
关键词
anaemia; cardiovascular function; haemoglobin; r-HuEPO;
D O I
10.1093/ndt/13.suppl_2.16
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
The optimal target haemoglobin during treatment with recombinant human erythropoietin (r-HuEPO) is still controversial. The impact of haemoglobin on cardiovascular function or survival, on physical performance and on medical rehabilitation have to be taken into consideration. Although currently there is no solid evidence to show that haemoglobin beyond that recommended by the nd hoc committee of the National Kidney Foundation improves survival, sound theoretical arguments can be offered for this proposition, particularly in cardiac patients. It is sensible to individualize the target haemoglobin and to avoid rapid correction of anaemia.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 50 条
[1]  
ADAMS WC, 1975, J APPL PHYSIOL, V39, P262, DOI 10.1152/jappl.1975.39.2.262
[2]  
AMANN K, 1995, NEPHROL DIAL TRANSPL, V10, P2043
[3]   CHANGES OF VASCULAR ARCHITECTURE-INDEPENDENT OF BLOOD-PRESSURE IN EXPERIMENTAL UREMIA [J].
AMANN, K ;
NEUSUSS, R ;
RITZ, E ;
IRZYNIEC, T ;
WIEST, G ;
MALL, G .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (04) :409-417
[4]   REDUCED CAPILLARY DENSITY IN THE MYOCARDIUM OF UREMIC RATS - A STEREOLOGICAL STUDY [J].
AMANN, K ;
WIEST, G ;
ZIMMER, G ;
GRETZ, N ;
RITZ, E ;
MALL, G .
KIDNEY INTERNATIONAL, 1992, 42 (05) :1079-1085
[5]  
AMANN K, 1997, ACTUALITES NEPHROLOG, P1
[6]  
ASTRAND PO, 1986, TXB WORK PSYCHOL
[7]   Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids [J].
BodeBoger, SM ;
Boger, RH ;
Kuhn, M ;
Radermacher, J ;
Frolich, JC .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1255-1261
[8]   BLOOD LACTATE IS REDUCED FOLLOWING SUCCESSFUL TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN BOTH AT REST AND AFTER MAXIMAL EXERTION [J].
DAVENPORT, A ;
WILL, EJ ;
KHANNA, SK ;
DAVISON, AM .
AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (05) :357-362
[9]   THE EFFECT OF TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN ON THE HISTOLOGICAL APPEARANCE AND GLYCOGEN-CONTENT OF SKELETAL-MUSCLE IN PATIENTS WITH CHRONIC-RENAL-FAILURE TREATED BY REGULAR HOSPITAL HEMODIALYSIS [J].
DAVENPORT, A ;
KING, RFGJ ;
IRONSIDE, JW ;
WILL, EJ ;
DAVISON, AM .
NEPHRON, 1993, 64 (01) :89-94
[10]   INFLUENCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON BLOOD-PRESSURE AND TISSUE RENIN-ANGIOTENSIN SYSTEMS [J].
EGGENA, P ;
WILLSEY, P ;
JAMGOTCHIAN, N ;
TRUCKENBROD, L ;
HU, MS ;
BARRETT, JD ;
EGGENA, MP ;
CLEGG, K ;
NAKHOUL, F ;
LEE, DBN .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05) :E642-E646